• 1469 Citations
  • 20 Scopus h-Index
20002019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Alvaro Moreno Aspitia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Anthracyclines Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 1469 Citations
  • 20 Scopus h-Index
  • 62 Article
12 Citations (Scopus)

Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients

Lambertini, M., Campbell, C., Bines, J., Korde, L. A., Izquierdo, M., Fumagalli, D., Del Mastro, L., Ignatiadis, M., Pritchard, K., Wolff, A. C., Jackisch, C., Lang, I., Untch, M., Smith, I., Boyle, F., Xu, B., Barrios, C. H., Baselga, J., Moreno Aspitia, A., Piccart, M. & 2 others, Gelber, R. D. & de Azambuja, E., Jan 1 2019, In : Journal of the National Cancer Institute. 111, 1, p. 86-94 9 p.

Research output: Contribution to journalArticle

Amenorrhea
Breast Neoplasms
Survival
Hormones
Therapeutics

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2

Dudenkov, T. M., Liu, D., Cairns, J., Devarajan, S., Zhuang, Y., Ingle, J. N., Buzdar, A. U., Robson, M. E., Kubo, M., Batzler, A., Barman, P., Jenkins, G. D., Carlson, E. E., Goetz, M. P., Northfelt, D. W., Moreno Aspitia, A., Desta, Z., Reid, J. M., Kalari, K. R., Wang, L. M. & 1 others, Weinshilboum, R. M., Jan 1 2019, In : Clinical pharmacology and therapeutics.

Research output: Contribution to journalArticle

Open Access
Aromatase Inhibitors
Genome-Wide Association Study
Single Nucleotide Polymorphism
Pharmaceutical Preparations
Breast Neoplasms
1 Citation (Scopus)

Are we assuming too much with our statistical assumptions? Lessons learned from the ALTTO trial

Holmes, E. M., Bradbury, I., Williams, L. S., Korde, L., De Azambuja, E., Fumagalli, D., Moreno-Aspitia, A., Baselga, J., Piccart-Gebhart, M., Dueck, A. C. & Gelber, R. D., Sep 1 2019, In : Annals of Oncology. 30, 9, p. 1507-1513 7 p.

Research output: Contribution to journalArticle

Randomized Controlled Trials
Medical Futility
Therapeutics
Patient Safety
Proportional Hazards Models
1 Citation (Scopus)
Technetium Tc 99m Sestamibi
Molecular Imaging
Breast
Breast Neoplasms
Drug Therapy

Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial

Lambertini, M., Campbell, C., Gelber, R. D., Viale, G., McCullough, A., Hilbers, F., Korde, L. A., Werner, O., Chumsri, S., Jackisch, C., Wolff, A. C., Vaz-Luis, I., Ferreira, A. R., Prat, A., Moreno Aspitia, A., Piccart, M., Loi, S. & de Azambuja, E., Aug 30 2019, In : Breast Cancer Research and Treatment. 177, 1, p. 103-114 12 p.

Research output: Contribution to journalArticle

Randomized Controlled Trials
Hormones
Breast Neoplasms
Disease-Free Survival
Neoplasms